GUOBIN WANG: Open Payments
NPI 1871850503 · FRESH MEADOWS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,458 in 91 payments from 11 companies in 2025. Trend: 2023 $802 · 2024 $1,373 · 2025 $1,458
Food & beverage: $1,292Education: $166
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $443 |
| Novartis Pharmaceuticals Corporation | 31 | $324 |
| Incyte Corporation | 15 | $209 |
| Organon LLC | 9 | $159 |
| ABBVIE INC. | 7 | $136 |
| Botanix SB Inc | 2 | $50 |
| LEO Pharma Inc. | 2 | $43 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $27 |
| Arcutis Biotherapeutics, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $22 |
Products named: TREMFYA, COSENTYX, OPZELURA, SKYRIZI, VTAMA, Rhapsido, SOFDRA, ANZUPGO.
Industry payments across NY — which companies pay providers there.
